Success Metrics

Clinical Success Rate
81.8%

Based on 9 completed trials

Completion Rate
82%(9/11)
Active Trials
0(0%)
Results Posted
56%(5 trials)
Terminated
2(17%)

Phase Distribution

Ph phase_3
2
17%
Ph phase_4
5
42%
Ph phase_1
2
17%
Ph phase_2
3
25%

Phase Distribution

2

Early Stage

3

Mid Stage

7

Late Stage

Phase Distribution12 total trials
Phase 1Safety & dosage
2(16.7%)
Phase 2Efficacy & side effects
3(25.0%)
Phase 3Large-scale testing
2(16.7%)
Phase 4Post-market surveillance
5(41.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

9 of 12 finished

Non-Completion Rate

25.0%

3 ended early

Currently Active

0

trials recruiting

Total Trials

12

all time

Status Distribution
Completed(9)
Terminated(3)

Detailed Status

Completed9
Terminated2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
0
Success Rate
81.8%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (16.7%)
Phase 23 (25.0%)
Phase 32 (16.7%)
Phase 45 (41.7%)

Trials by Status

completed975%
withdrawn18%
terminated217%

Recent Activity

0 active trials
Showing 5 of 12
completedphase_1

Penetration of Ceftaroline Into Cerebrospinal Fluid(CSF)

NCT02806882
completedphase_1

Ceftaroline for Treatment of Hematogenously Acquired Staphylococcus Aureus Osteomyelitis in Children

NCT02335905
terminatedphase_2

Safety, Tolerability and Efficacy of Ceftaroline in Paediatrics With Late-Onset Sepsis

NCT02424734
completedphase_3

Evaluation of Ceftaroline Fosamil Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections

NCT01499277
terminatedphase_3

Evaluation of Ceftaroline Fosamil vs Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections.

NCT02202135
View all 12 trials

Clinical Trials (12)

Showing 12 of 12 trials
NCT02806882Phase 1

Penetration of Ceftaroline Into Cerebrospinal Fluid(CSF)

Completed
NCT02335905Phase 1

Ceftaroline for Treatment of Hematogenously Acquired Staphylococcus Aureus Osteomyelitis in Children

Completed
NCT02424734Phase 2

Safety, Tolerability and Efficacy of Ceftaroline in Paediatrics With Late-Onset Sepsis

Terminated
NCT01499277Phase 3

Evaluation of Ceftaroline Fosamil Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections

Completed
NCT02202135Phase 3

Evaluation of Ceftaroline Fosamil vs Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections.

Terminated
NCT01645735Phase 4

Evaluation of Ceftaroline Fosamil Versus a Comparator in Adult Subjects With Community-acquired Bacterial Pneumonia (CABP) With Risk for Methicillin-resistant Staphylococcus Aureus

Completed
NCT01669980Phase 4

Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Complicated Community Acquired Pneumonia (CABP)

Completed
NCT01530763Phase 2

Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Community Acquired Bacterial Pneumonia (CABP)

Completed
NCT01400867Phase 2

Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Complicated Skin Infections

Completed
NCT01701219Phase 4

Safety and Efficacy Study of Ceftaroline in Subjects With Staphylococcus Aureus Bacteremia or With Persistent Methicillin-Resistant Staphylococcus Aureus Bacteremia

Completed
NCT01298843Phase 4

Study of Blood Levels of Ceftaroline Fosamil in Children Who Are Receiving Antibiotic Therapy in the Hospital

Completed
NCT01666743Phase 4

Safety and Efficacy Study of Ceftaroline in Elderly Subjects With Community-Acquired Bacterial Pneumonia

Withdrawn

All 12 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
12